Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Researchers Show How a Tumor Cell’s Location and Environment Affect Its Identity

June 23, 2023 - NCATS News

New approach could provide insights into cancer progression and treatment response, leading to more precise therapies.

NCATS Scientists Turn Stem Cells Into Vast Supply of Neurons to Better Predict Pain Therapies’ Effectiveness

June 14, 2023 - NCATS News

  • Our Impact on Tools and Technologies

NCATS researchers and collaborators test possible new pain-relieving drugs in the laboratory on nerve cells.

Genetics Experts Support Adding Hundreds of Treatable Rare Diseases to Newborn Screening

May 9, 2023 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

A study found that 88% of experts surveyed on rare diseases agreed that DNA testing to reveal treatable genetic disorders should be available for all infants. This additional screening could allow lifesaving treatments to be delivered to babies sooner.

Artificial Intelligence Is Advancing Clinical Research and Data Quality

April 25, 2023 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program
  • Our Impact on Big Data

NCATS awardees use small business funding and CTSA Program grants to commercialize a customizable natural language processing software. The software captures and analyzes large amounts of data, facilitating improved clinical and biological research.

Better Method for Growing Stem Cells Could Speed Gene-Editing Therapies

April 7, 2023 - NCATS News

  • Stem Cell Translation Laboratory (SCTL)

Scientists have published step-by-step instructions on how to use a four-part cocktail of drugs and compounds to grow stem cells from a single cell.

FDA-Approved Drug Shows Promise in Lab Models for Blinding Childhood Disease

March 29, 2023 - NCATS News

Strategy may speed delivery of therapeutic options relative to time it would take to develop gene therapies.

Last updated on July 9, 2026